BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17014578)

  • 1. Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Okamaoto R; Ikeda H; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1197-205. PubMed ID: 17014578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis.
    Miyake Y; Iwasaki Y; Terada R; Takagi S; Okamaoto R; Ikeda H; Sakai N; Makino Y; Kobashi H; Takaguchi K; Sakaguchi K; Shiratori Y
    J Hepatol; 2005 Dec; 43(6):951-7. PubMed ID: 16143423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy.
    Seela S; Sheela H; Boyer JL
    Liver Int; 2005 Aug; 25(4):734-9. PubMed ID: 15998423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    Johnson PJ; McFarlane IG; Williams R
    N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.
    Hino T; Kumashiro R; Ide T; Koga Y; Ishii K; Tanaka E; Morita Y; Hisamochi A; Murashima S; Tanaka K; Ogata K; Kuwahara R; Sata M;
    Int J Mol Med; 2003 Jun; 11(6):749-55. PubMed ID: 12736717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience.
    Kanzler S; Löhr H; Gerken G; Galle PR; Lohse AW
    Z Gastroenterol; 2001 May; 39(5):339-41, 344-8. PubMed ID: 11413913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
    Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
    Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
    Rebollo Bernárdez J; Cifuentes Mimoso C; Piñar Moreno A; Caunedo Alvarez A; Salas Herrero E; Jiménez-Sáenz M; Herrerías Gutiérrez J
    Rev Esp Enferm Dig; 1999 Sep; 91(9):630-8. PubMed ID: 10502711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
    Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2008 Aug; 103(8):1944-51. PubMed ID: 18564111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study).
    Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Ohta H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Komori A; Ito M; Yatsuhashi H; Nakamura M; Ishibashi H;
    Liver Int; 2012 May; 32(5):837-44. PubMed ID: 22221966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
    Olsson R; Boberg KM; de Muckadell OS; Lindgren S; Hultcrantz R; Folvik G; Bell H; Gangsøy-Kristiansen M; Matre J; Rydning A; Wikman O; Danielsson A; Sandberg-Gertzén H; Ung KA; Eriksson A; Lööf L; Prytz H; Marschall HU; Broomé U
    Gastroenterology; 2005 Nov; 129(5):1464-72. PubMed ID: 16285948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.